Today's Research Report Coverage on Medical Equipment Stocks -- Prestige Brands, Smith & Nephew, Steris, and Varian Medical Systems

Thursday, June 29, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 29, 2017 /PRNewswire/ --

If you want a Stock Review on PBH, SNN, STE or VAR then come over to

and sign up for your free customized report today. Medical Appliances and Equipment space is engaged in the manufacture of medical instruments such as dental and surgical appliances. Companies in this category tend to offer below-average dividend yields
when compared to the wider market. This morning, evaluates the following four stocks: Prestige Brands Holdings Inc. (NYSE: PBH), Smith & Nephew PLC (NYSE: SNN), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks by signing up for their free reports on at:

Prestige Brands 

On Wednesday, shares in Tarrytown, New York headquartered Prestige Brands Holdings Inc. recorded a trading volume of 295.67 thousand shares. The stock ended the session 0.02% higher at $52.74. The Company's shares have gained 5.71% in the last one month and 1.23% on an YTD basis. The stock is trading 1.51% above its 200-day moving average. Moreover, shares of Prestige Brands Holdings, which through its subsidiaries, markets, sells, manufactures, and distributes over-the-counter healthcare and household cleaning products in North America, Australia, and internationally, have a Relative Strength Index (RSI) of 51.44.

On June 02nd, 2017, research firm Jefferies upgraded the Company's stock rating from 'Underperform' to 'Hold'. The free research report on PBH is available at:

Smith & Nephew 

London, the UK headquartered Smith & Nephew PLC's stock closed the day 1.04% higher at $35.11 with a total trading volume of 375.85 thousand shares. The Company's shares have advanced 13.33% in the previous three months and 7.60% in the past twelve months. The stock is trading 2.45% and 11.94% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Smith & Nephew, which designs, develops, and sells medical devices worldwide, have an RSI of 54.55. The complimentary report on SNN can be downloaded at:


Shares in Leicester, the UK headquartered Steris PLC recorded a trading volume of 687.75 thousand shares. The stock ended yesterday's trading session 1.04% higher at $82.32. The Company's shares have advanced 6.81% in the past month, 19.56% in the last three months, and 26.61% in the last twelve months. The stock is trading 7.03% and 16.03% above its 50-day and 200-day moving averages, respectively. Furthermore, shares of Steris, which develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide,  have an RSI of 64.63.

On June 05th, 2017, research firm Wellington Shields downgraded the Company's stock rating from 'Gradually Accumulate' to 'Hold'. Visit us today and download our complete research report on STE for free at:

Varian Medical Systems 

Palo Alto, California headquartered Varian Medical Systems Inc.'s stock finished Wednesday's session 0.39% lower at $102.25 with a total trading volume of 2.19 million shares. The Company's shares have advanced 3.51% in the past month, 12.19% in the last three months, and 45.77% in the last twelve months. The stock is trading 5.29% and 17.65% above its 50-day and 200-day moving averages, respectively. Shares of Varian Medical Systems, which designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide, have an RSI of 57.35. Get free access to your technical report on VAR at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store